| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Structure Therapeutics Inc. | CHIEF SCIENTIFIC OFFICER | American Depositary Shares | 0 | $0 | $50.00 | Jun 3, 2024 | Direct |
| Structure Therapeutics Inc. | CHIEF SCIENTIFIC OFFICER | Share Option (right to buy) | 214K | Jun 3, 2024 | Direct | ||
| Structure Therapeutics Inc. | CHIEF SCIENTIFIC OFFICER | Stock Option (right to buy) | 213K | Mar 15, 2024 | Direct | ||
| Structure Therapeutics Inc. | CHIEF SCIENTIFIC OFFICER | Employee Stock Option (right to buy) | 196K | Mar 15, 2025 | Direct | ||
| Structure Therapeutics Inc. | CHIEF SCIENTIFIC OFFICER | Ordinary Shares | 167K | Mar 15, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GPCR | Structure Therapeutics Inc. | Mar 15, 2025 | 2 | $0 | 4 | Mar 18, 2025 | CHIEF SCIENTIFIC OFFICER |
| GPCR | Structure Therapeutics Inc. | Jun 3, 2024 | 6 | -$1.65M | 4 | Jun 5, 2024 | CHIEF SCIENTIFIC OFFICER |
| GPCR | Structure Therapeutics Inc. | Mar 15, 2024 | 1 | $0 | 4/A | Mar 20, 2024 | CHIEF SCIENTIFIC OFFICER |
| GPCR | Structure Therapeutics Inc. | Mar 15, 2024 | 2 | $0 | 4 | Mar 19, 2024 | CHIEF SCIENTIFIC OFFICER |
| GPCR | Structure Therapeutics Inc. | Feb 2, 2023 | 0 | $0 | 3 | Feb 2, 2023 | Chief Scientific Officer |